1146 related articles for article (PubMed ID: 16542282)
1. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey.
Wong WM; Lim P; Wong BC
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S54-60. PubMed ID: 15324383
[TBL] [Abstract][Full Text] [Related]
3. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
4. Management of reflux disease in clinical praxis in hungary.
Hritz I; Prónai L; Szalay F; Tulassay Z
Z Gastroenterol; 2005 Jun; 43(6):575-80. PubMed ID: 15986286
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal disorders in patients with gastroesophageal reflux disease.
Farrokhi F; Vaezi MF
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):181-7. PubMed ID: 17557046
[TBL] [Abstract][Full Text] [Related]
6. Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey.
Chey WD; Inadomi JM; Booher AM; Sharma VK; Fendrick AM; Howden CW
Am J Gastroenterol; 2005 Jun; 100(6):1237-42. PubMed ID: 15929751
[TBL] [Abstract][Full Text] [Related]
7. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
Issing WJ; Gross M; Tauber S
Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
[TBL] [Abstract][Full Text] [Related]
8. [ENT manifestations of gastroesophageal reflux disease (GERD)].
Watanabe Y
Nihon Rinsho; 2004 Aug; 62(8):1533-6. PubMed ID: 15344546
[TBL] [Abstract][Full Text] [Related]
9. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
10. [Gastroesophageal reflux involvement in ENT disorders].
Drug VL; Cobzeanu D; Papaghiuc C; Ciochină P; Gogălniceanu P; Bugioianoun C; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):220-2. PubMed ID: 16607774
[TBL] [Abstract][Full Text] [Related]
11. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
12. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management?
Ellis KK; Oehlke M; Helfand M; Lieberman D
Am J Gastroenterol; 1997 Sep; 92(9):1472-4. PubMed ID: 9317065
[TBL] [Abstract][Full Text] [Related]
13. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
14. Acid reflux management: ENT perspective.
Ahmad I; Batch AJ
J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
[TBL] [Abstract][Full Text] [Related]
16. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
17. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
18. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
Katzka DA; Paoletti V; Leite L; Castell DO
Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
[TBL] [Abstract][Full Text] [Related]
19. Extra-esophageal manifestations of gastroesophageal reflux.
Farrokhi F; Vaezi MF
Oral Dis; 2007 Jul; 13(4):349-59. PubMed ID: 17577320
[TBL] [Abstract][Full Text] [Related]
20. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
Qua CS; Wong CH; Gopala K; Goh KL
Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
